<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id><journal-id journal-id-type="publisher-id">JVMS</journal-id><journal-title-group><journal-title>The Journal of Veterinary Medical Science</journal-title></journal-title-group><issn pub-type="ppub">0916-7250</issn><issn pub-type="epub">1347-7439</issn><publisher><publisher-name>The Japanese Society of Veterinary Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29057764</article-id><article-id pub-id-type="pmc">5745181</article-id><article-id pub-id-type="publisher-id">16-0658</article-id><article-id pub-id-type="doi">10.1292/jvms.16-0658</article-id><article-categories><subj-group subj-group-type="heading"><subject>Surgery</subject><subj-group><subject>Full Paper</subject></subj-group></subj-group></article-categories><title-group><article-title>Evaluation of total intravenous anesthesia with
propofol-guaifenesin-medetomidine and alfaxalone-guaifenesin-medetomidine in Thoroughbred
horses undergoing castration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>AOKI</surname><given-names>Motoki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>WAKUNO</surname><given-names>Ai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>KUSHIRO</surname><given-names>Asuka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MAE</surname><given-names>Naomi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KAKIZAKI</surname><given-names>Masashi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>NAGATA</surname><given-names>Shun-ichi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>OHTA</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1)</label>Racehorse Clinic, Miho Training Center, Japan Racing
Association, Ibaraki 300-0493, Japan</aff><aff id="aff2"><label>2)</label>Laboratory of Racing Chemistry, Tochigi 320-0851,
Japan</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Wakuno, A.: <email xlink:href="Ai_Wakuno@jra.go.jp">Ai_Wakuno@jra.go.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2017</year></pub-date><volume>79</volume><issue>12</issue><fpage>2011</fpage><lpage>2018</lpage><history><date date-type="received"><day>05</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>01</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;2017 The Japanese Society of Veterinary Science</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0:
<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>)</license-p></license></permissions><abstract><p>Anesthetic and cardiorespiratory effects of total intravenous anesthesia (TIVA) technique
using propofol-guaifenesin-medetomidine (PGM) and alfaxalone-guaifenesin-medetomidine
(AGM) were preliminarily evaluated in Thoroughbred horses undergoing castration. Twelve
male Thoroughbred horses were assigned randomly into two groups. After premedication with
intravenous (IV) administrations of medetomidine (5.0 <italic>&#x000b5;</italic>g/kg) and
butorphanol (0.02 mg/kg), anesthesia was induced with guaifenesin (10 mg/kg IV), followed
by either propofol (2.0 mg/kg IV) (group PGM: n=6) or alfaxalone (1.0 mg/kg IV) (group
AGM: n=6). Surgical anesthesia was maintained for 60 min at a constant infusion of either
propofol (3.0 mg/kg/hr) (group PGM) or alfaxalone (1.5 mg/kg/hr) (group AGM), in
combination with guaifenesin (80 mg/kg/hr) and medetomidine (3.0
<italic>&#x000b5;</italic>g/kg/hr). Responses to surgical stimuli, cardiorespiratory values, and
induction and recovery characteristics were recorded throughout anesthesia. During
anesthesia induction, one horse paddled in group PGM. All horses from group AGM were
maintained at adequate anesthetic depth for castration. In group PGM, 3 horses showed
increased cremaster muscle tension and one showed slight movement requiring additional IV
propofol to maintain surgical anesthesia. No horse exhibited apnea, although arterial
oxygen tension decreased in group AGM to less than 60 mmHg. Recovery quality was good to
excellent in both groups. In conclusion, TIVA using PGM and AGM infusion was available for
60 min anesthesia in Thoroughbred horses. TIVA techniques using PGM and AGM infusion
provided clinically acceptable general anesthesia with mild cardiorespiratory depression.
However, inspired air should be supplemented with oxygen to prevent hypoxemia during
anesthesia.</p></abstract><kwd-group><kwd>alfaxalone</kwd><kwd>horse</kwd><kwd>propofol</kwd><kwd>TIVA</kwd></kwd-group></article-meta></front><body><p>In horses, surgical procedures requiring anesthesia for more than 30 min can be realized with
simultaneous infusions of ketamine, &#x003b1;<sub>2</sub>-adrenoceptor agonists
(&#x003b1;<sub>2</sub>-agonists), and centrally acting muscle relaxants. The combination of
guaifenesin, ketamine and xylazine (&#x0201c;Triple drip&#x0201d;) has been popularized since 1986 [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r35" ref-type="bibr">35</xref>, <xref rid="r47" ref-type="bibr">47</xref>]. In current
equine practice, Triple drip is one of the most commonly used total intravenous anesthesia
(TIVA) techniques under field conditions. This technique and its modifications using different
&#x003b1;<sub>2</sub>-agonists or water-soluble benzodiazepines can be safely administered for 90
min in horses [<xref rid="r24" ref-type="bibr">24</xref>, <xref rid="r25" ref-type="bibr">25</xref>].</p><p>Ketamine is a dissociative anesthetic that has been used for induction of anesthesia and TIVA
in horses for a long time [<xref rid="r15" ref-type="bibr">15</xref>]. However, ketamine may
become unavailable in many countries due to its international scheduling in near future.
Therefore, it is an urgent problem to develop a TIVA regimen that does not involve the use of
ketamine. It is expected that propofol and alfaxalone may overcome this concern because of
their pharmacokinetic properties in horses [<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r38" ref-type="bibr">38</xref>].</p><p>Propofol (2, 6-diisopropylphenol) is an injectable anesthetic agent that acts on the gamma
aminobutyric acid GABA<sub>A</sub> receptors in the central nervous system. It is a popular
intravenous (IV) anesthetic used in humans, dogs and cats, and its anesthetic effect is
characterized by a smooth and rapid onset and short duration of action [<xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r43" ref-type="bibr">43</xref>]. Furthermore, propofol is
suitable for TIVA in horses because it does not produce active metabolites and exhibits
minimal accumulation when administered for infusion over 60 min in ponies [<xref rid="r38" ref-type="bibr">38</xref>]. However, it was reported that unpredictable behavioral
responses, including paddling or myotonus in the front half of the body, can be frequently
observed during the induction of anesthesia with propofol in horses [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r40" ref-type="bibr">40</xref>]. In addition, an infusion of propofol alone is inappropriate for maintenance of
anesthesia because of its poor analgesic properties and tendency to cause respiratory
depression in horses [<xref rid="r30" ref-type="bibr">30</xref>, <xref rid="r37" ref-type="bibr">37</xref>]. Therefore, propofol is used as a maintenance agent in combination with
analgesics, such as &#x003b1;<sub>2</sub>-agonists, opioids, ketamine and lidocaine, but exclusively
in research settings [<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r30" ref-type="bibr">30</xref>, <xref rid="r37" ref-type="bibr">37</xref>, <xref rid="r41" ref-type="bibr">41</xref>].</p><p>Medetomidine has high selectivity for &#x003b1;<sub>2</sub>-adrenergic receptors and produces potent
&#x003b1;<sub>2</sub>-adrenergic effects, including muscle relaxation, central nervous system
depression and analgesia in horses [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r44" ref-type="bibr">44</xref>]. TIVA techniques using a combination of propofol and
medetomidine have been reported to produce clinically adequate anesthetic conditions for
surgical procedures [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r39" ref-type="bibr">39</xref>]. However, Oku <italic>et al</italic>. [<xref rid="r39" ref-type="bibr">39</xref>] reported that a brief period of apnea was observed in 3 out of 6 horses castrated
under propofol-medetomidine TIVA. Moreover, Bettschart-Wolfensberger <italic>et al</italic>.
[<xref rid="r4" ref-type="bibr">4</xref>] reported that 23 of 50 horses anesthetized with
propofol-medetomidine TIVA required positive pressure ventilation to overcome hypoventilation.
As such, propofol-induced respiratory depression during maintenance of anesthesia remains an
important clinical concern if mechanical ventilation is not available, such as in conditions
of field anesthesia.</p><p>Guaifenesin is a centrally acting muscle relaxant that is widely used in equine anesthesia as
a constituent of Triple drip as mentioned above. Guaifenesin prevents unpredictable adverse
behavioral responses, for example paddling, during the anesthetic induction with propofol
[<xref rid="r6" ref-type="bibr">6</xref>]. The respiratory depression produced during the
propofol-medetomidine TIVA may be reduced by co-administration of guaifenesin, which indicates
a possibility of decreasing the infusion dose of propofol required for maintaining surgical
anesthesia. Therefore, it is worthwhile to investigate TIVA technique using a combination of
propofol, guaifenesin and medetomidine in horses.</p><p>Alfaxalone (3&#x003b1;-hydroxy-5&#x003b1;-pregnane-11, 20-dione) is a synthetic neuroactive steroid that acts
on the GABA<sub>A</sub> receptors in the central nervous system, resulting in loss of
consciousness and muscle relaxation. Alfaxalone has similar clinical characteristics to
propofol [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r10" ref-type="bibr">10</xref>]
and has been used for induction of anesthesia in many animal species [<xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r33" ref-type="bibr">33</xref>]. In horses, alfaxalone showed similar anesthetic induction and recovery
effects and cardiorespiratory responses to ketamine and thiopental [<xref rid="r45" ref-type="bibr">45</xref>]. In addition, alfaxalone has desirable pharmacokinetic characteristics
for TIVA, and is rapidly eliminated from the plasma in horses [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r22" ref-type="bibr">22</xref>]. Therefore, alfaxalone may be a
possible alternative to ketamine that constitutes Triple drip and its modifications. It is
worthwhile to investigate TIVA technique using a combination of alfaxalone, guaifenesin and
medetomidine in horses. In addition, no published data regarding changes in plasma alfaxalone
concentration in horses that received alfaxalone infusion are currently available.</p><p>The present study was designed to preliminary evaluate anesthetics and cardiorespiratory
effects of TIVA techniques using an infusion of propofol-guaifenesin-medetomidine (PGM-TIVA)
or alfaxalone-guaifenesin-medetomidine (AGM-TIVA) in horses. Time course changes in plasma
concentrations of alfaxalone were also measured during and after AGM infusion. We hypothesized
that both PGM-TIVA and AGM-TIVA techniques might provide appropriate surgical anesthesia for
castration in Thoroughbred horses.</p><sec sec-type="materials|methods" id="s1"><title>MATERIALS AND METHODS</title><sec><title>Horses</title><p>Twelve male race-retired Thoroughbred horses scheduled for surgical castration were
assigned randomly into two groups (PGM group: n=6; AGM group: n=6). The median age and
body weights were 3.6 years (range: 3.2&#x02013;4.3 years) and 468 kg (range: 420&#x02013;520 kg) in group
PGM, and 3.3 years (range: 2.1&#x02013;3.4 years) and 454 kg (range: 420&#x02013;480 kg) in group AGM,
respectively. No abnormality was detected on the general physical examination, the
pre-anesthetic blood examination and electrocardiography in any horse. Food, but not
water, was withheld for 12 hr prior to anesthesia. All horses were treated with
intramuscular (IM) administration of penicillin (8,000 IU/kg: Mycillin Inj NZ, Nippon
Zenyaku Kogyo Co., Ltd., Fukushima, Japan) and flunixin meglumine (1 mg/kg IV: Banamine
injection-5%, DS Pharma Animal Health Co., Ltd., Osaka, Japan) before surgery. This study
was performed according to the Guidelines for Animal Experiments at the Equine Research
Institute, Japan Racing Association.</p></sec><sec><title>Anesthesia and surgical protocol</title><p>A 14-gauge, 60-mm catheter was placed in the left external jugular vein in both groups
for drug administration, and a second catheter was placed in the right external jugular
vein for collection of venous blood samples in group AGM. The horses were premedicated
with medetomidine (5.0 <italic>&#x000b5;</italic>g/kg IV: Domitor, Orion Corp., Espoo, Finland)
and butorphanol (0.02 mg/kg IV: Vetorphale, Meiji Seika Co., Ltd., Tokyo, Japan). Ten min
after premedication, anesthesia was induced with guaifenesin (10 mg/kg IV: 5% Guaifenesin,
Shinyo Pure Chemicals Co., Ltd., Osaka, Japan) followed immediately by either propofol
(2.0 mg/kg IV: 1% Propofol, Nichi-Iko Pharmaceutical Co., Ltd., Toyama, Japan) (group PGM)
or alfaxalone (1.0 mg/kg IV: Alfaxan, Jurox Pty Ltd., NSW, Australia) (group AGM).</p><p>Horses were then positioned in left lateral recumbency on a padded surgical mat.
Thereafter, surgical anesthesia was maintained for 60 min with constant rate infusion
(CRI) of either propofol (3.0 mg/kg/hr) (group PGM) or alfaxalone (1.5 mg/kg/hr) (group
AGM), in combination with guaifenesin (80 mg/kg/hr CRI) and medetomidine (3.0
<italic>&#x000b5;</italic>g/kg/hr CRI). Propofol or alfaxalone, guaifenesin and medetomidine
were mixed together in one bottle and administered using an infusion pump (IVAC 599,
Cardinal Health 303 Inc., San Diego, CA, U.S.A.) via the primary line. Horses were allowed
to spontaneously breathe atmospheric air throughout anesthesia. The surgeons administered
a 400 mg of lidocaine (2% Xylocaine, AstraZeneca Co., Ltd., Osaka, Japan) into each
testicle 10 min before the start of surgery.</p><p>The syringes and fluid lines were covered by the black tapes, so that the surgeons were
blinded to anesthetic drug combination that the horses received. A junior surgeon
performed the castration using a semi-closed surgical technique under the supervision of
an experienced surgeon. The same surgeons performed procedures throughout the study. In
order to equalize the operation time, surgeries were performed between 15&#x02013;45 min after the
start of the PGM or AGM infusion. Surgical conditions (the cremaster muscle tension and
movement against surgical stimuli) were assessed by the surgeons, and an additional IV
dose of either propofol (0.5 mg/kg) (group PGM) or alfaxalone (0.25 mg/kg) (group AGM) was
administered if the surgeon judged the level of anesthesia to be inadequate for surgery.
Horses were allowed to recover unassisted and received no additional drugs.</p></sec><sec><title>Anesthetic monitoring</title><p>The time from the end of anesthetic drug administration to the time when horses became
lateral recumbent (induction time) was recorded. The quality of induction was subjectively
assessed by 2 experienced anesthetists who were blinded to anesthetic drug combination
using a scoring scale of 1&#x02013;5 (1: poor, 2: marginal, 3: fair, 4: good, 5: excellent), as
previously described [<xref rid="r27" ref-type="bibr">27</xref>].</p><p>Heart rate (HR) and respiratory rate (RR) were recorded by auscultation and visually
before premedication (baseline) and every 10 min after starting the CRI of anesthetic drug
combination. A 20-gauge, 51-mm catheter was placed in the facial or transverse facial
artery, and systolic arterial blood pressure (SAP), mean arterial blood pressure (MAP),
and diastolic arterial blood pressure (DAP) were monitored using a multipurpose monitoring
system (BSM-2301, Nihon Kohden Co., Ltd., Tokyo, Japan) every 10 min. The
electrocardiogram was continuously monitored using a standard base-apex lead configuration
immediately after the induction of anesthesia. Arterial blood samples were collected at
the same time of cardiovascular monitoring and arterial oxygen tension (PaO<sub>2</sub>),
arterial carbon dioxide tension (PaCO<sub>2</sub>), and arterial blood pH were immediately
analyzed using a blood gas analyzer (ABL800 FLEX, Radiometer Co., Ltd., Tokyo, Japan). The
typical signs of anesthetic depth (eye position, nystagmus, palpebral reflex and muscle
tone) were continuously monitored.</p><p>The time from the end of PGM or AGM infusion to the first movement, sternal recumbency,
the first attempt to stand and standing (recovery time) were recorded. The quality of
recovery was assessed by anesthetists who were blinded to the anesthetic drug combination
using the same scoring scale [<xref rid="r27" ref-type="bibr">27</xref>].</p></sec><sec><title>Plasma alfaxalone analysis</title><p>Blood samples of 10 m<italic>l</italic> were collected from the right external jugular
catheter at 15, 30, 45 and 60 min of anesthesia and immediately after standing in group
AGM. All blood samples were immediately placed on ice, and the plasma was separated from
blood and frozen at &#x02212;20&#x000b0;C.</p><p>Alfaxalone was recovered from plasma samples by liquid-liquid extraction using methyl
tert-butyl ether, with 11-hydroxy progesterone as the internal standard. The extracted
substance was analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) by
electrospray ionization in positive ion mode. LC-MS/MS system consisted of Shimadzu
prominence HPLC system (Shimadzu Co., Tokyo, Japan) and AB Sciex QTRAP 4000 mass
spectrometer (AB Sciex, Framingham, MA, U.S.A.). The calibration was performed using
linear standard curves in the range of 10&#x02013;500 mg/<italic>l</italic>, and the coefficient
of correlation (r<sup>2</sup>) exceeded 0.995. The lower limit of quantification was 10
<italic>n</italic>g/m<italic>l</italic>, and the recovery and repeatability were 94.0
and 4.8%, respectively. Analysis of data was performed using SAAM-II program (University
of Washington, Seattle, WA, U.S.A.).</p></sec><sec><title>Statistical analysis</title><p>All results were expressed as medians (range). Statistical analysis of data was carried
out using JMP 8 (SAS Institute Japan Ltd., Tokyo, Japan). Cardiorespiratory data were
analyzed using Friedman&#x02019;s test. The Mann-Whitney <italic>U</italic> test (between the
groups) and Steel test (between baseline and each subsequent measurement point within
group) were used when significant differences were observed. Induction and recovery data
between the groups were compared using the Mann-Whitney <italic>U</italic> test, and the
level of statistical significance was set at <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results" id="s2"><title>RESULTS</title><p>Induction quality scores and induction times are shown in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Induction and recovery quality scores and times of total intravenous anesthesia
using propofol-guaifenesin-medetomidine (Group PGM) and
alfaxalone-guaifenesin-medetomidine (Group AGM)</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1"/><th align="center" rowspan="1" colspan="1">Group PGM</th><th align="center" rowspan="1" colspan="1">Group AGM</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td colspan="2" rowspan="1">Induction quality score</td><td align="center" rowspan="1" colspan="1">4 (1&#x02013;5)</td><td align="center" rowspan="1" colspan="1">5 (4&#x02013;5)</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td align="center" colspan="2" rowspan="1">Time from the end of anesthetic induction drug administration</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">to lateral recumbency (sec)</td><td align="center" rowspan="1" colspan="1">46 (40&#x02013;65)</td><td align="center" rowspan="1" colspan="1">49 (41&#x02013;61)</td><td align="center" rowspan="1" colspan="1">0.48</td></tr><tr><td colspan="2" align="left" rowspan="1">Recovery quality score</td><td align="center" rowspan="1" colspan="1">4 (3&#x02013;5)</td><td align="center" rowspan="1" colspan="1">5 (3&#x02013;5)</td><td align="center" rowspan="1" colspan="1">0.54</td></tr><tr><td colspan="2" align="left" rowspan="1">Time from the end of constant rate infusion</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">to the first movement (min)</td><td align="center" rowspan="1" colspan="1">22 (12&#x02013;42)</td><td align="center" rowspan="1" colspan="1">32 (29&#x02013;40)</td><td align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">to sternal recumbency (min)</td><td align="center" rowspan="1" colspan="1">31 (17&#x02013;55)</td><td align="center" rowspan="1" colspan="1">51 (43&#x02013;79)</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">to the first attempt to stand (min)</td><td align="center" rowspan="1" colspan="1">37 (31&#x02013;64)</td><td align="center" rowspan="1" colspan="1">56 (45&#x02013;79)</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">to standing (min)</td><td align="center" rowspan="1" colspan="1">43 (32&#x02013;64)</td><td align="center" rowspan="1" colspan="1">56 (45&#x02013;79)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (range).</p></table-wrap-foot></table-wrap>. No significant differences in induction quality score were observed between
the groups. All horses from group AGM and 5 of 6 horses from group PGM scored 4 (good) or
higher. One horse in group PGM scored 1 (poor) because the horse excited with severe
muscular tremors and rigidity during transition to lateral recumbency and paddled its front
and hindlimbs for approximately one min after attaining lateral recumbency. The time from
the end of induction drug administration to lateral recumbency was similar in both
groups.</p><p>Intermittent nystagmus or blinking was observed throughout anesthesia in both groups.
Surgeons judged that anesthesia level of all horses from group AGM was adequately maintained
for castration, and no additional IV administration of alfaxalone was required. In group
PGM, surgeons commented on increased cremaster muscle tension in 3 out of 6 horses, and
slight ear and/or limbs movement was observed in one of these horses in response to surgical
stimulation. This horse exhibited gross purposeful movement with hypertension (SAP&#x0003e;200
mmHg) at 20 min and an additional dose of propofol (0.5 mg/kg IV) was administered to
achieve a sufficient level of anesthesia for surgery.</p><p>The time course changes in cardiorespiratory variables are shown in <xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Heart rate (HR), systolic arterial blood pressure (SAP), mean arterial blood
pressure (MAP), diastolic arterial blood pressure (DAP), respiratory rate (RR),
arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2) and blood pH
in horses anesthetized with total intravenous anesthesia technique using
propofol-guaifenesin-medetomidine (Group PGM: n=6) and
alfaxalone-guaifenesin-medetomidine (Group AGM: n=6) before premedication (baseline)
and at every 10 min of anesthesia</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" valign="top" align="left" rowspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Baseline</th><th valign="top" align="center" rowspan="1" colspan="1">10 min</th><th valign="top" align="center" rowspan="1" colspan="1">20 min</th><th valign="top" align="center" rowspan="1" colspan="1">30 min</th><th valign="top" align="center" rowspan="1" colspan="1">40 min</th><th valign="top" align="center" rowspan="1" colspan="1">50 min</th><th valign="top" align="center" rowspan="1" colspan="1">60 min</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="2" rowspan="1">HR (beats/min)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">36 (30&#x02013;48)</td><td align="center" valign="top" rowspan="1" colspan="1">22 (20&#x02013;28)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">24 (20&#x02013;43)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (20&#x02013;46)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (20&#x02013;44)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (20&#x02013;42)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (25&#x02013;33)<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">36 (30&#x02013;36)</td><td align="center" valign="top" rowspan="1" colspan="1">25 (24&#x02013;30)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">26 (24&#x02013;30)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">27 (25&#x02013;31)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">27 (23&#x02013;32)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">28 (24&#x02013;34)</td><td align="center" valign="top" rowspan="1" colspan="1">28 (25&#x02013;33)<sup>a</sup></td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">SAP (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">129 (118&#x02013;170)</td><td align="center" valign="top" rowspan="1" colspan="1">123 (107&#x02013;223)</td><td align="center" valign="top" rowspan="1" colspan="1">123 (110&#x02013;185)</td><td align="center" valign="top" rowspan="1" colspan="1">123 (107&#x02013;154)</td><td align="center" valign="top" rowspan="1" colspan="1">123 (107&#x02013;150)</td><td align="center" valign="top" rowspan="1" colspan="1">115 (103&#x02013;130)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">150 (130&#x02013;162)</td><td align="center" valign="top" rowspan="1" colspan="1">140 (125&#x02013;162)</td><td align="center" valign="top" rowspan="1" colspan="1">139 (125&#x02013;159)</td><td align="center" valign="top" rowspan="1" colspan="1">141 (123&#x02013;157)</td><td align="center" valign="top" rowspan="1" colspan="1">138 (123&#x02013;152)</td><td align="center" valign="top" rowspan="1" colspan="1">134 (116&#x02013;149)</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">MAP (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">103 (84&#x02013;130)</td><td align="center" valign="top" rowspan="1" colspan="1">97 (90&#x02013;164)</td><td align="center" valign="top" rowspan="1" colspan="1">98 (91&#x02013;142)</td><td align="center" valign="top" rowspan="1" colspan="1">98 (86&#x02013;133)</td><td align="center" valign="top" rowspan="1" colspan="1">95 (85&#x02013;122)</td><td align="center" valign="top" rowspan="1" colspan="1">89 (83&#x02013;111)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">117 (108&#x02013;135)</td><td align="center" valign="top" rowspan="1" colspan="1">113 (100&#x02013;136)</td><td align="center" valign="top" rowspan="1" colspan="1">110 (95&#x02013;133)</td><td align="center" valign="top" rowspan="1" colspan="1">111 (89&#x02013;131)</td><td align="center" valign="top" rowspan="1" colspan="1">109 (90&#x02013;128)</td><td align="center" valign="top" rowspan="1" colspan="1">105 (92&#x02013;125)</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">DAP (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">87 (70&#x02013;110)</td><td align="center" valign="top" rowspan="1" colspan="1">82 (77&#x02013;142)</td><td align="center" valign="top" rowspan="1" colspan="1">83 (81&#x02013;127)</td><td align="center" valign="top" rowspan="1" colspan="1">81 (75&#x02013;119)</td><td align="center" valign="top" rowspan="1" colspan="1">80 (67&#x02013;107)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (70&#x02013;98)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">100 (92&#x02013;120)</td><td align="center" valign="top" rowspan="1" colspan="1">100 (83&#x02013;121)</td><td align="center" valign="top" rowspan="1" colspan="1">97 (80&#x02013;117)</td><td align="center" valign="top" rowspan="1" colspan="1">97 (72&#x02013;115)</td><td align="center" valign="top" rowspan="1" colspan="1">95 (73&#x02013;111)</td><td align="center" valign="top" rowspan="1" colspan="1">92 (75&#x02013;107)</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">RR (breaths/min)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">15 (12&#x02013;18)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (7&#x02013;12)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">10 (6&#x02013;12)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">10 (5&#x02013;12)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">9 (5&#x02013;12)<sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">9 (5&#x02013;16)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (5&#x02013;12)<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">12 (12&#x02013;15)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (3&#x02013;10)<sup>a,b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">5 (3&#x02013;9)<sup>a,b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">5 (3&#x02013;9)<sup>a,b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">5 (4&#x02013;8)<sup>a,b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">5 (4&#x02013;8)<sup>a,b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">5 (4&#x02013;9)<sup>a,b</sup></td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">PaO<sub>2</sub> (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">66.6 (61.8&#x02013;67.9)</td><td align="center" valign="top" rowspan="1" colspan="1">64.2 (59.1&#x02013;66.4)</td><td align="center" valign="top" rowspan="1" colspan="1">63.1 (58.4&#x02013;69.0)</td><td align="center" valign="top" rowspan="1" colspan="1">60.8 (57.8&#x02013;65.9)</td><td align="center" valign="top" rowspan="1" colspan="1">63.8 (60.5&#x02013;70.7)</td><td align="center" valign="top" rowspan="1" colspan="1">61.4 (57.8&#x02013;67.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">55.5 (40.9&#x02013;57.4)<sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">55.4 (41.0&#x02013;58.8)<sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">54.5 (36.0&#x02013;55.8)<sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">54.6 (38.0&#x02013;57.4)<sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">54.9 (38.1&#x02013;60.0)<sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">54.1 (39.8&#x02013;59.1)<sup>b</sup></td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">PaCO<sub>2</sub> (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">50.8 (46.6&#x02013;57.0)</td><td align="center" valign="top" rowspan="1" colspan="1">51.6 (48.2&#x02013;57.2)</td><td align="center" valign="top" rowspan="1" colspan="1">51.3 (47.5&#x02013;57.8)</td><td align="center" valign="top" rowspan="1" colspan="1">52.7 (49.0&#x02013;59.0)</td><td align="center" valign="top" rowspan="1" colspan="1">53.5 (48.1&#x02013;58.6)</td><td align="center" valign="top" rowspan="1" colspan="1">53.9 (49.2&#x02013;60.9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">50.8 (49.1&#x02013;53.4)</td><td align="center" valign="top" rowspan="1" colspan="1">51.2 (49.1&#x02013;54.5)</td><td align="center" valign="top" rowspan="1" colspan="1">52.4 (50.6&#x02013;55.6)</td><td align="center" valign="top" rowspan="1" colspan="1">54.1 (50.4&#x02013;55.9)</td><td align="center" valign="top" rowspan="1" colspan="1">55.1 (51.6&#x02013;60.0)</td><td align="center" valign="top" rowspan="1" colspan="1">55.9 (51.4&#x02013;59.2)</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">pH</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group PGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.37&#x02013;7.39)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.37&#x02013;7.38)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.36&#x02013;7.40)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.35&#x02013;7.39)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.35&#x02013;7.39)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.35&#x02013;7.38)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Group AGM</td><td align="center" valign="top" rowspan="1" colspan="1">n/a</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.37&#x02013;7.39)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.36&#x02013;7.40)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (7.35&#x02013;7.39)</td><td align="center" valign="top" rowspan="1" colspan="1">7.37 (7.36&#x02013;7.38)</td><td align="center" valign="top" rowspan="1" colspan="1">7.37 (7.34&#x02013;7.38)</td><td align="center" valign="top" rowspan="1" colspan="1">7.36 (7.34&#x02013;7.39)</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (range). n/a: not available. a) Significantly different
from baseline values within the groups (<italic>P</italic>&#x0003c;0.05). b) Significantly
different between two groups (<italic>P</italic>&#x0003c;0.05).</p></table-wrap-foot></table-wrap>. No significant differences in HR were observed between the groups at any time
points. No cardiac arrhythmia was detected throughout anesthesia. No significant differences
in SAP, MAP or DAP, either between the groups or between any time points, were detected,
although one horse showed hypertension at 20 min in response to surgical stimuli as
mentioned above.</p><p>During anesthesia, horses from group PGM showed relatively shallow and Cheyne-stokes
breathing, while the horses in group AGM exhibited relatively deep, slow and stable
breathing patterns. When compared to baseline values, RR in group PGM was significantly
reduced at all time points except at 50 min. The RR in group AGM was significantly lower
than baseline values at all time points and significantly lower than that in group PGM.
However, no horse of either group exhibited apnea for more than one min. PaO<sub>2</sub>,
PaCO<sub>2</sub> and pH did not change significantly over time in either group. No
significant differences were observed in PaCO<sub>2</sub> and pH between the groups, while
PaO<sub>2</sub> values in group AGM were significantly lower than those in group PGM
throughout anesthesia. Hypoxemia (PaO<sub>2</sub>&#x0003c;60 mmHg) was evident in 2 out of 6
horses in group PGM and in all 6 horses from group AGM.</p><p>Recovery quality scores and recovery times are also shown in <xref rid="tbl_001" ref-type="table">Table 1</xref>. Recoveries were uneventful in all cases, and no
significant differences were observed in recovery quality score between the groups. No
significant differences were detected in the time from the end of PGM or AGM infusion to the
first movement, sternal recumbency, the first attempt to stand and standing.</p><p>Changes in plasma alfaxalone concentration during anesthesia and after standing in group
AGM are shown in <xref ref-type="fig" rid="fig_001">Fig. 1.</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Changes in plasma alfaxalone concentration (<italic>&#x000b5;</italic>g/m<italic>l</italic>)
during anesthesia and after standing in horses anesthetized with total intravenous
anesthesia using infusions of alfaxalone, guaifenesin and medetomidine (n=6). Blood
samples were collected at 15, 30, 45 and 60 min of anesthesia and immediately after
standing. Plots are mean values and error bars are standard deviations from 6
horses.</p></caption><graphic xlink:href="jvms-79-2011-g001"/></fig> Mean plasma alfaxalone concentration was stable throughout anesthesia (1.58&#x02013;1.71
<italic>&#x000b5;</italic>g/m<italic>l</italic>) and decreased rapidly after anesthesia
(0.48 <italic>&#x000b5;</italic>g/m<italic>l</italic>).</p></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>In ponies, the administration of propofol after premedication with &#x003b1;<sub>2</sub>-agonists
(xylazine or detomidine) has been reported to produce smooth induction with good muscle
relaxation [<xref rid="r36" ref-type="bibr">36</xref>, <xref rid="r37" ref-type="bibr">37</xref>]. In contrast, in the study of adult horses that received propofol (2.0 mg/kg
IV) after premedication with detomidine (15 <italic>&#x000b5;</italic>g/kg IV), two out of 12 horses
showed signs of excitement and one of them exhibited paddling activity after recumbency
[<xref rid="r30" ref-type="bibr">30</xref>]. Ohta <italic>et al</italic>. [<xref rid="r41" ref-type="bibr">41</xref>] reported that Thoroughbred race horses that received
propofol (3.0 mg/kg IV) after premedication with xylazine (1.0 mg/kg IV) and midazolam (50
<italic>&#x000b5;</italic>g/kg IV) also showed similar results. These excitatory behaviors were
unpredictable as all horses appeared to be well sedated before induction. Conversely, it has
been reported that guaifenesin (73 &#x000b1; 18 mg/kg IV) [<xref rid="r6" ref-type="bibr">6</xref>]
or (90 mg/kg IV) [<xref rid="r28" ref-type="bibr">28</xref>] prevented adverse anesthetic
induction events caused by propofol. In the present study, guaifenesin (10 mg/kg IV) was
combined with propofol, and one horse from group PGM was excited with severe muscular
tremors and rigidity during transition to lateral recumbency and paddled its front and
hindlimbs for approximately one min after attaining lateral recumbency. This was possibly
due to the fact that guaifenesin dose used in the present study was very small compared to
that in previous studies [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r28" ref-type="bibr">28</xref>]. In the present study, a low dose of guaifenesin combined with
medetomidine and butorphanol was adopted considering the situation of field anesthesia and
the need to avoid cumbersome equipment. However, there are still some concerns regarding
quality during induction with propofol.</p><p>Wakuno <italic>et al.</italic> [<xref rid="r45" ref-type="bibr">45</xref>] reported that 2
out of 6 Thoroughbred horses that received IV alfaxalone after premedication with
medetomidine (5.0 <italic>&#x000b5;</italic>g/kg IV) and midazolam (0.02 mg/kg IV) showed slight
muscular rigidity or limb movement during transition to lateral recumbency. Keates
<italic>et al</italic>. [<xref rid="r21" ref-type="bibr">21</xref>] reported that
anesthesia induction with alfaxalone (1.0 mg/kg IV) following premedication with xylazine
(0.5 mg/kg IV) and guaifenesin (35 mg/kg IV) resulted in limb rigidity in 5 out of 6 horses.
Conversely, it has been reported that induction with alfaxalone (1.0 mg/kg IV) following
premedication with acepromazine (0.03 mg/kg IV), medetomidine (7.0 <italic>&#x000b5;</italic>g/kg
IV) and guaifenesin (35 mg/kg IV) provided smooth transition to lateral recumbency and
favorable conditions for tracheal intubation in horses [<xref rid="r13" ref-type="bibr">13</xref>]. In the present study, anesthesia induction was smooth in all horses
anesthetized with alfaxalone (1.0 mg/kg IV) following the premedication with medetomidine
(5.0 <italic>&#x000b5;</italic>g/kg IV), butorphanol (0.02 mg/kg IV) and guaifenesin (10 mg/kg IV),
even though the dose of guaifenesin was small compared to that used in previous studies (35
mg/kg) [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r21" ref-type="bibr">21</xref>]. Therefore, it is expected that the combination of low dose guaifenesin,
medetomidine and butorphanol may improve the induction quality of alfaxalone.</p><p>The infusion rates of AGM in the present study were determined on the basis of our
preliminary experimental studies (unpublished data) and a previous report [<xref rid="r13" ref-type="bibr">13</xref>]. Goodwin <italic>et al</italic>. [<xref rid="r13" ref-type="bibr">13</xref>] reported that alfaxalone (2.0 mg/kg/hr CRI) and
medetomidine (5.0 <italic>&#x000b5;</italic>g/kg/hr CRI) provided an adequate level of surgical
anesthesia for castration and no additional doses or increases in infusion rates were
required. In the present study, the infusion rate of alfaxalone required to maintain
surgical anesthesia for castration in horses was effectively reduced by 25% compared to that
reported by Goodwin <italic>et al.</italic> [<xref rid="r13" ref-type="bibr">13</xref>],
using infusions of guaifenesin and medetomidine.</p><p>The infusion rates of PGM in the present study were selected on the basis of previous
reports [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r15" ref-type="bibr">15</xref>,
<xref rid="r39" ref-type="bibr">39</xref>]. Bettschart-Wolfensberger <italic>et
al</italic>. [<xref rid="r4" ref-type="bibr">4</xref>] reported that supplemental ketamine
was required in 17 horses, and 14 of these horses required additional thiopental to maintain
surgical anesthesia among 50 clinical horses in which anesthesia was maintained with
propofol (5.9&#x02013;6.5 mg/kg/hr CRI) and medetomidine (3.5 <italic>&#x000b5;</italic>g/kg/hr CRI) for
elective surgery. Oku <italic>et al</italic>. [<xref rid="r39" ref-type="bibr">39</xref>]
reported that propofol (6.0 mg/kg/hr CRI) and medetomidine (3.0 <italic>&#x000b5;</italic>g/kg/hr
CRI) provided an adequate level of surgical anesthesia for castration in 4 out of 7 horses,
while additional IV administration of propofol or thiopental was required in the remaining 3
horses. From these results, 6.0 mg/kg/hr of propofol was considered to be the minimum
infusion rate required to achieve surgical levels of anesthesia when combined with
medetomidine (3.0&#x02013;3.5 <italic>&#x000b5;</italic>g/kg/hr CRI). Therefore, the infusion rate of
propofol was set at 3.0 mg/kg/hr with the expectation that the addition of guaifenesin would
reduce propofol requirement. However, the TIVA technique with PGM infusion resulted in
movements in response to surgical stimuli in 3 out of 6 horses. Therefore, this propofol
infusion rate (3.0 mg/kg/hr CRI) seemed to be insufficient to achieve the surgical depth of
anesthesia for castration in horses anesthetized with the PGM-TIVA technique. Because the
infusions of guaifenesin and medetomidine might produce 25% reduction in alfaxalone
requirement as mentioned above, it was supposed that 4.5 mg/kg/hr of propofol infusion rate
might provide an adequate anesthetic effect for castration in horses under PGM-TIVA.</p><p>In the present study, HR and arterial blood pressures were stable throughout anesthesia in
both groups. Although HR values were significantly lower during anesthesia than baseline
values, they remained within commonly acceptable limits for horses under general anesthesia.
Generally, a MAP&#x0003e;70 mmHg is considered necessary for prevention of postoperative
myopathy. While blood pressure was slightly elevated in horses anesthetized with PGM-TIVA
and AGM-TIVA, MAPs were maintained at comparable value as with other similar TIVA techniques
[<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r39" ref-type="bibr">39</xref>].
Yamashita <italic>et al</italic>. [<xref rid="r46" ref-type="bibr">46</xref>] reported that
an IV injection of medetomidine induced increases in peripheral vascular resistance in
horses. Therefore, it was considered that the increases in peripheral vascular resistance
due to medetomidine might contribute to the high blood pressure. Although the evaluation of
cardiovascular function was limited to HR and blood pressure in the present study, it
appeared that cardiovascular functions were maintained within an acceptable level during
anesthesia in horses anesthetized with PGM-TIVA and AGM-TIVA.</p><p>Both propofol and alfaxalone are known to cause apnea when used in high doses in dogs
[<xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r34" ref-type="bibr">34</xref>].
During PGM-TIVA or AGM-TIVA, spontaneous respiration was maintained in all horses, although
mild hypercapnia (PaCO<sub>2</sub>=55&#x02013;60 mmHg) developed. The horses anesthetized with
PGM-TIVA showed relatively shallow and Cheyne-stokes breathing with significantly higher RR,
while the horses anesthetized with AGM-TIVA exhibited relatively deep, slow and stable
breathing patterns with significantly lower RR. Although these breathing patterns varied
between individual horses, these differences in respiration seemed to reflect the
insufficient depth of anesthesia in horses anesthetized with PGM-TIVA as mentioned above.
While the tidal volume was not measured in the present study, it was suggested that the
minute ventilation might be maintained at acceptable levels during PGM-TIVA and AGM-TIVA,
because the horses developed only mild hypercapnia. In contrast, PaO<sub>2</sub> values
during anesthesia were remarkably lower than the expected values in horses that were awake
and breathing air. Ventilation perfusion mismatch resulting from recumbent postures were
likely to cause severe hypoxemia, which is a common problem in field anesthesia [<xref rid="r9" ref-type="bibr">9</xref>]. Alfaxalone induction in horses premedicated with
xylazine and guaifenesin caused hypoxemia (PaO<sub>2</sub>&#x0003c;55 mmHg) because of
ventilation perfusion mismatching rather than respiratory depression due to the drugs
administered [<xref rid="r21" ref-type="bibr">21</xref>]. Although the
P<sub>(A-a)</sub>O<sub>2</sub> values were not measured in the present study, it was
considered that comparable factors induced hypoxemia in horses anesthetized with PGM-TIVA
and AGM-TIVA. Nasotracheal oxygen insufflation might help improving PaO<sub>2</sub> values,
but it is necessary to examine the details in cardiorespiratory function in horses
anesthetized with PGM-TIVA and AGM-TIVA.</p><p>It was reported that the majority of horses anesthetized with alfaxalone 3.0 mg/kg/hr CRI
for 3 hr showed excitement and hyperesthesia shortly after the cessation of alfaxalone
infusion [<xref rid="r12" ref-type="bibr">12</xref>]. These undesirable behaviors were not
observed in horses anesthetized with AGM-TIVA, and this was possibly due to the fact that
the total infusion dose of alfaxalone was much lower in these horses than those used in a
previous report [<xref rid="r12" ref-type="bibr">12</xref>]. On the other hand, Goodwin
<italic>et al.</italic> [<xref rid="r13" ref-type="bibr">13</xref>] reported that the
horses anesthetized with infusions of alfaxalone (2.0 mg/kg/hr CRI) and medetomidine (5.0
<italic>&#x000b5;</italic>g/kg/hr CRI) for 45 min stood on their first attempt and their
recoveries were judged good to excellent. However, total anesthesia time was much shorter in
the present study compared to the previous report [<xref rid="r13" ref-type="bibr">13</xref>]. In the present study, recoveries were uneventful and smooth in all horses.
Median recovery times were also considered appropriate for the duration of anesthesia.
Sedation with an &#x003b1;<sub>2</sub>-agonist during the recovery period prevents early movement
and improves the quality of recovery in horses [<xref rid="r18" ref-type="bibr">18</xref>,
<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r42" ref-type="bibr">42</xref>].
Although plasma medetomidine concentration was not measured in the present study, it was
considered that a residual sedative effect of medetomidine after the cessation of its CRI
might prevent excitation during recovery period.</p><p>The mean plasma concentration of alfaxalone during surgery ranged from approximately 1.6 to
1.7 <italic>&#x000b5;</italic>g/m<italic>l</italic> and rapidly decreased after the cessation of
alfaxalone infusion. The mean plasma concentration of alfaxalone was approximately 0.5
<italic>&#x000b5;</italic>g/m<italic>l</italic> in standing horses (median, 56 min; range, 45&#x02013;79
min). The eliminating half-time was roughly estimated at approximately 40 min; this value
was close to the elimination half-time following a 1.0 mg/kg of bolus IV alfaxalone (33.4
min) in horses [<xref rid="r14" ref-type="bibr">14</xref>]. It was reconfirmed that
alfaxalone has a suitable pharmacokinetic effect when used with TIVA in horses.</p><p>In conclusion, TIVA techniques using PGM and AGM infusions provided clinically acceptable
general anesthesia with mild cardiorespiratory depression in horses. These TIVA techniques
may be useful for a moderate period (60 min) of anesthesia, although propofol infusion rate
should be reexamined. However, inspired air should be supplemented with oxygen to prevent
hypoxemia during anesthesia.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Ambros</surname><given-names>B.</given-names></name><name><surname>Duke-Novakovski</surname><given-names>T.</given-names></name><name><surname>Pasloske</surname><given-names>K. S.</given-names></name></person-group><year>2008</year>. <article-title>Comparison of the anesthetic efficacy and
cardiopulmonary effects of continuous rate infusions of
alfaxalone-2-hydroxypropyl-beta-cyclodextrin and propofol in dogs</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>69</volume>:
<fpage>1391</fpage>&#x02013;<lpage>1398</lpage>. doi: <pub-id pub-id-type="doi">10.2460/ajvr.69.11.1391</pub-id><pub-id pub-id-type="pmid">18980420</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Baetge</surname><given-names>C. L.</given-names></name><name><surname>Matthews</surname><given-names>N. S.</given-names></name><name><surname>Carroll</surname><given-names>G. L.</given-names></name></person-group><year>2007</year>
<article-title>Comparison of 3 total intravenous
anesthetic infusion combinations in adult horses</article-title>. <source><italic>Int.
J. Appl. Res. Vet. Med.</italic></source><volume>5</volume>:
<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Bettschart-Wolfensberger</surname><given-names>R.</given-names></name><name><surname>Freeman</surname><given-names>S. L.</given-names></name><name><surname>J&#x000e4;ggin-Schmucker</surname><given-names>N.</given-names></name><name><surname>Clarke</surname><given-names>K. W.</given-names></name></person-group><year>2001</year>. <article-title>Infusion of a combination of propofol and
medetomidine for long-term anesthesia in ponies</article-title>. <source><italic>Am. J.
Vet. Res.</italic></source><volume>62</volume>: <fpage>500</fpage>&#x02013;<lpage>507</lpage>.
doi: <pub-id pub-id-type="doi">10.2460/ajvr.2001.62.500</pub-id><pub-id pub-id-type="pmid">11327455</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Bettschart-Wolfensberger</surname><given-names>R.</given-names></name><name><surname>Kalchofner</surname><given-names>K.</given-names></name><name><surname>Neges</surname><given-names>K.</given-names></name><name><surname>K&#x000e4;stner</surname><given-names>S.</given-names></name><name><surname>F&#x000fc;rst</surname><given-names>A.</given-names></name></person-group><year>2005</year>. <article-title>Total intravenous anaesthesia in horses
using medetomidine and propofol</article-title>. <source><italic>Vet. Anaesth.
Analg.</italic></source><volume>32</volume>: <fpage>348</fpage>&#x02013;<lpage>354</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2005.00202.x</pub-id><pub-id pub-id-type="pmid">16297044</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Bettschart-Wolfensberger</surname><given-names>R.</given-names></name><name><surname>Bowen</surname><given-names>M. I.</given-names></name><name><surname>Freeman</surname><given-names>S. L.</given-names></name><name><surname>Feller</surname><given-names>R.</given-names></name><name><surname>Bettschart</surname><given-names>R. W.</given-names></name><name><surname>Nolan</surname><given-names>A.</given-names></name><name><surname>Clarke</surname><given-names>K. W.</given-names></name></person-group><year>2001</year>. <article-title>Cardiopulmonary effects of prolonged
anesthesia via propofol-medetomidine infusion in ponies</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>62</volume>:
<fpage>1428</fpage>&#x02013;<lpage>1435</lpage>. doi: <pub-id pub-id-type="doi">10.2460/ajvr.2001.62.1428</pub-id><pub-id pub-id-type="pmid">11560273</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Brosnan</surname><given-names>R. J.</given-names></name><name><surname>Steffey</surname><given-names>E. P.</given-names></name><name><surname>Escobar</surname><given-names>A.</given-names></name><name><surname>Palazoglu</surname><given-names>M.</given-names></name><name><surname>Fiehn</surname><given-names>O.</given-names></name></person-group><year>2011</year>. <article-title>Anesthetic induction with guaifenesin and
propofol in adult horses</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>72</volume>: <fpage>1569</fpage>&#x02013;<lpage>1575</lpage>. doi:
<pub-id pub-id-type="doi">10.2460/ajvr.72.12.1569</pub-id><pub-id pub-id-type="pmid">22126682</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Bryant</surname><given-names>C. E.</given-names></name><name><surname>England</surname><given-names>G. C.</given-names></name><name><surname>Clarke</surname><given-names>K. W.</given-names></name></person-group><year>1991</year>. <article-title>Comparison of the sedative effects of
medetomidine and xylazine in horses</article-title>. <source><italic>Vet.
Rec.</italic></source><volume>129</volume>: <fpage>421</fpage>&#x02013;<lpage>423</lpage>. doi:
<pub-id pub-id-type="doi">10.1136/vr.129.19.421</pub-id><pub-id pub-id-type="pmid">1776221</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Bueno</surname><given-names>A. C.</given-names></name><name><surname>Cornick-Seahorn</surname><given-names>J.</given-names></name><name><surname>Seahorn</surname><given-names>T. L.</given-names></name><name><surname>Hosgood</surname><given-names>G.</given-names></name><name><surname>Moore</surname><given-names>R. M.</given-names></name></person-group><year>1999</year>. <article-title>Cardiopulmonary and sedative effects of
intravenous administration of low doses of medetomidine and xylazine to adult
horses</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>60</volume>: <fpage>1371</fpage>&#x02013;<lpage>1376</lpage>.
<pub-id pub-id-type="pmid">10566811</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Coutu</surname><given-names>P.</given-names></name><name><surname>Caulkett</surname><given-names>N.</given-names></name><name><surname>Pang</surname><given-names>D.</given-names></name><name><surname>Boysen</surname><given-names>S.</given-names></name></person-group><year>2015</year>. <article-title>Efficacy of a portable oxygen
concentrator with pulsed delivery for treatment of hypoxemia during equine field
anesthesia</article-title>. <source><italic>Vet. Anaesth.
Analg.</italic></source><volume>42</volume>: <fpage>518</fpage>&#x02013;<lpage>526</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/vaa.12246</pub-id><pub-id pub-id-type="pmid">25683480</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Ferr&#x000e9;</surname><given-names>P. J.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name><name><surname>Whittem</surname><given-names>T.</given-names></name><name><surname>Ranasinghe</surname><given-names>M. G.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Lefebvre</surname><given-names>H. P.</given-names></name></person-group><year>2006</year>. <article-title>Plasma pharmacokinetics of alfaxalone in
dogs after an intravenous bolus of Alfaxan-CD RTU</article-title>. <source><italic>Vet.
Anaesth. Analg.</italic></source><volume>33</volume>:
<fpage>229</fpage>&#x02013;<lpage>236</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2005.00264.x</pub-id><pub-id pub-id-type="pmid">16764587</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Flaherty</surname><given-names>D.</given-names></name><name><surname>Reid</surname><given-names>J.</given-names></name><name><surname>Welsh</surname><given-names>E.</given-names></name><name><surname>Monteiro</surname><given-names>A. M.</given-names></name><name><surname>Lerche</surname><given-names>P.</given-names></name><name><surname>Nolan</surname><given-names>A.</given-names></name></person-group><year>1997</year>. <article-title>A pharmacodynamic study of propofol or
propofol and ketamine infusions in ponies undergoing surgery</article-title>.
<source><italic>Res. Vet. Sci.</italic></source><volume>62</volume>:
<fpage>179</fpage>&#x02013;<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0034-5288(97)90143-0</pub-id><pub-id pub-id-type="pmid">9243720</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="conf"><person-group><name><surname>Goodwin</surname><given-names>W. A.</given-names></name><name><surname>Keates</surname><given-names>H. L.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name></person-group><year>2009</year> Total intravenous anaesthesia (TIVA) in the horse with
alfaxalone (abstract). p. 87. <italic>In</italic>: Proceedings of the 10th World Congress
of Veterinary Anaesthesiology, Glasgow.</mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Goodwin</surname><given-names>W. A.</given-names></name><name><surname>Keates</surname><given-names>H. L.</given-names></name><name><surname>Pearson</surname><given-names>M.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name></person-group><year>2013</year>. <article-title>Alfaxalone and medetomidine intravenous
infusion to maintain anaesthesia in colts undergoing field castration</article-title>.
<source><italic>Equine Vet. J.</italic></source><volume>45</volume>:
<fpage>315</fpage>&#x02013;<lpage>319</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.2042-3306.2012.00645.x</pub-id><pub-id pub-id-type="pmid">23004224</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Goodwin</surname><given-names>W. A.</given-names></name><name><surname>Keates</surname><given-names>H. L.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name><name><surname>Pearson</surname><given-names>M.</given-names></name><name><surname>Sauer</surname><given-names>B.</given-names></name><name><surname>Ranasinghe</surname><given-names>M. G.</given-names></name></person-group><year>2011</year>. <article-title>The pharmacokinetics and pharmacodynamics
of the injectable anaesthetic alfaxalone in the horse</article-title>.
<source><italic>Vet. Anaesth. Analg.</italic></source><volume>38</volume>:
<fpage>431</fpage>&#x02013;<lpage>438</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2011.00634.x</pub-id><pub-id pub-id-type="pmid">21831048</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Greene</surname><given-names>S. A.</given-names></name><name><surname>Thurmon</surname><given-names>J. C.</given-names></name><name><surname>Tranquilli</surname><given-names>W. J.</given-names></name><name><surname>Benson</surname><given-names>G. J.</given-names></name></person-group><year>1986</year>. <article-title>Cardiopulmonary effects of continuous
intravenous infusion of guaifenesin, ketamine, and xylazine in ponies</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>47</volume>:
<fpage>2364</fpage>&#x02013;<lpage>2367</lpage>. <pub-id pub-id-type="pmid">3789495</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Grimsrud</surname><given-names>K. N.</given-names></name><name><surname>Mama</surname><given-names>K. R.</given-names></name><name><surname>Steffey</surname><given-names>E. P.</given-names></name><name><surname>Stanley</surname><given-names>S. D.</given-names></name></person-group><year>2012</year>. <article-title>Pharmacokinetics and pharmacodynamics of
intravenous medetomidine in the horse</article-title>. <source><italic>Vet. Anaesth.
Analg.</italic></source><volume>39</volume>: <fpage>38</fpage>&#x02013;<lpage>48</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1467-2995.2011.00669.x</pub-id><pub-id pub-id-type="pmid">22103480</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Grint</surname><given-names>N. J.</given-names></name><name><surname>Smith</surname><given-names>H. E.</given-names></name><name><surname>Senior</surname><given-names>J. M.</given-names></name></person-group><year>2008</year>. <article-title>Clinical evaluation of alfaxalone in
cyclodextrin for the induction of anaesthesia in rabbits</article-title>.
<source><italic>Vet. Rec.</italic></source><volume>163</volume>:
<fpage>395</fpage>&#x02013;<lpage>396</lpage>. doi: <pub-id pub-id-type="doi">10.1136/vr.163.13.395</pub-id><pub-id pub-id-type="pmid">18820329</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Ida</surname><given-names>K. K.</given-names></name><name><surname>Fantoni</surname><given-names>D. T.</given-names></name><name><surname>Ibiapina</surname><given-names>B. T.</given-names></name><name><surname>Souto</surname><given-names>M. T.</given-names></name><name><surname>Zoppa</surname><given-names>A. L.</given-names></name><name><surname>Silva</surname><given-names>L. C.</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>A. M.</given-names></name></person-group><year>2013</year>. <article-title>Effect of postoperative xylazine
administration on cardiopulmonary function and recovery quality after isoflurane
anesthesia in horses</article-title>. <source><italic>Vet.
Surg.</italic></source><volume>42</volume>: <fpage>877</fpage>&#x02013;<lpage>884</lpage>.
<pub-id pub-id-type="pmid">24033770</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Ishizuka</surname><given-names>T.</given-names></name><name><surname>Itami</surname><given-names>T.</given-names></name><name><surname>Tamura</surname><given-names>J.</given-names></name><name><surname>Saitoh</surname><given-names>Y.</given-names></name><name><surname>Saitoh</surname><given-names>M.</given-names></name><name><surname>Umar</surname><given-names>M. A.</given-names></name><name><surname>Miyoshi</surname><given-names>K.</given-names></name><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Muir</surname><given-names>W. W.</given-names></name></person-group><year>2013</year>. <article-title>Anesthetic and cardiorespiratory effects
of propofol, medetomidine, lidocaine and butorphanol total intravenous anesthesia in
horses</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>75</volume>: <fpage>165</fpage>&#x02013;<lpage>172</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.12-0203</pub-id><pub-id pub-id-type="pmid">23059840</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Keates</surname><given-names>H.</given-names></name></person-group><year>2003</year>. <article-title>Induction of anaesthesia in pigs using a
new alphaxalone formulation</article-title>. <source><italic>Vet.
Rec.</italic></source><volume>153</volume>: <fpage>627</fpage>&#x02013;<lpage>628</lpage>. doi:
<pub-id pub-id-type="doi">10.1136/vr.153.20.627</pub-id><pub-id pub-id-type="pmid">14653343</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Keates</surname><given-names>H. L.</given-names></name><name><surname>van Eps</surname><given-names>A. W.</given-names></name><name><surname>Pearson</surname><given-names>M. R.</given-names></name></person-group><year>2012</year>. <article-title>Alfaxalone compared with ketamine for
induction of anaesthesia in horses following xylazine and guaifenesin</article-title>.
<source><italic>Vet. Anaesth. Analg.</italic></source><volume>39</volume>:
<fpage>591</fpage>&#x02013;<lpage>598</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2012.00756.x</pub-id><pub-id pub-id-type="pmid">22823480</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Kl&#x000f6;ppel</surname><given-names>H.</given-names></name><name><surname>Leece</surname><given-names>E. A.</given-names></name></person-group><year>2011</year>. <article-title>Comparison of ketamine and alfaxalone for
induction and maintenance of anaesthesia in ponies undergoing
castration</article-title>. <source><italic>Vet. Anaesth.
Analg.</italic></source><volume>38</volume>: <fpage>37</fpage>&#x02013;<lpage>43</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1467-2995.2010.00584.x</pub-id><pub-id pub-id-type="pmid">21214708</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Langley</surname><given-names>M. S.</given-names></name><name><surname>Heel</surname><given-names>R. C.</given-names></name></person-group><year>1988</year>. <article-title>Propofol. A review of its pharmacodynamic
and pharmacokinetic properties and use as an intravenous anaesthetic</article-title>.
<source><italic>Drugs</italic></source><volume>35</volume>:
<fpage>334</fpage>&#x02013;<lpage>372</lpage>. doi: <pub-id pub-id-type="doi">10.2165/00003495-198835040-00002</pub-id><pub-id pub-id-type="pmid">3292208</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Lerche</surname><given-names>P.</given-names></name></person-group><year>2013</year>. <article-title>Total intravenous anesthesia in
horses</article-title>. <source><italic>Vet. Clin. North Am. Equine
Pract.</italic></source><volume>29</volume>: <fpage>123</fpage>&#x02013;<lpage>129</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.cveq.2012.11.008</pub-id><pub-id pub-id-type="pmid">23498048</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Luna</surname><given-names>S. P.</given-names></name><name><surname>Taylor</surname><given-names>P. M.</given-names></name><name><surname>Bloomfield</surname><given-names>M.</given-names></name></person-group><year>1997</year>. <article-title>Endocrine changes in cerebrospinal fluid,
pituitary effluent, and peripheral plasma of anesthetized ponies</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>58</volume>:
<fpage>765</fpage>&#x02013;<lpage>770</lpage>. <pub-id pub-id-type="pmid">9215455</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Mama</surname><given-names>K. R.</given-names></name><name><surname>Steffey</surname><given-names>E. P.</given-names></name><name><surname>Pascoe</surname><given-names>P. J.</given-names></name></person-group><year>1995</year>. <article-title>Evaluation of propofol as a general
anesthetic for horses</article-title>. <source><italic>Vet.
Surg.</italic></source><volume>24</volume>: <fpage>188</fpage>&#x02013;<lpage>194</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1532-950X.1995.tb01317.x</pub-id><pub-id pub-id-type="pmid">7778261</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Mama</surname><given-names>K. R.</given-names></name><name><surname>Steffey</surname><given-names>E. P.</given-names></name><name><surname>Pascoe</surname><given-names>P. J.</given-names></name></person-group><year>1996</year>. <article-title>Evaluation of propofol for general
anesthesia in premedicated horses</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>57</volume>: <fpage>512</fpage>&#x02013;<lpage>516</lpage>.
<pub-id pub-id-type="pmid">8712516</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Mama</surname><given-names>K. R.</given-names></name><name><surname>Pascoe</surname><given-names>P. J.</given-names></name><name><surname>Steffey</surname><given-names>E. P.</given-names></name><name><surname>Kollias-Baker</surname><given-names>C.</given-names></name></person-group><year>1998</year>. <article-title>Comparison of two techniques for total
intravenous anesthesia in horses</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>59</volume>: <fpage>1292</fpage>&#x02013;<lpage>1298</lpage>.
<pub-id pub-id-type="pmid">9781464</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Maney</surname><given-names>J. K.</given-names></name><name><surname>Shepard</surname><given-names>M. K.</given-names></name><name><surname>Braun</surname><given-names>C.</given-names></name><name><surname>Cremer</surname><given-names>J.</given-names></name><name><surname>Hofmeister</surname><given-names>E. H.</given-names></name></person-group><year>2013</year>. <article-title>A comparison of cardiopulmonary and
anesthetic effects of an induction dose of alfaxalone or propofol in
dogs</article-title>. <source><italic>Vet. Anaesth.
Analg.</italic></source><volume>40</volume>: <fpage>237</fpage>&#x02013;<lpage>244</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/vaa.12006</pub-id><pub-id pub-id-type="pmid">23331573</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Matthews</surname><given-names>N. S.</given-names></name><name><surname>Hartsfield</surname><given-names>S. M.</given-names></name><name><surname>Hague</surname><given-names>B.</given-names></name><name><surname>Carroll</surname><given-names>G. L.</given-names></name><name><surname>Short</surname><given-names>C. E.</given-names></name></person-group><year>1999</year>. <article-title>Detomidine-propofol anesthesia for
abdominal surgery in horses</article-title>. <source><italic>Vet.
Surg.</italic></source><volume>28</volume>: <fpage>196</fpage>&#x02013;<lpage>201</lpage>. doi:
<pub-id pub-id-type="doi">10.1053/jvet.1999.0196</pub-id><pub-id pub-id-type="pmid">10338166</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Matthews</surname><given-names>N. S.</given-names></name><name><surname>Hartsfield</surname><given-names>S. M.</given-names></name><name><surname>Mercer</surname><given-names>D.</given-names></name><name><surname>Beleau</surname><given-names>M. H.</given-names></name><name><surname>MacKenthun</surname><given-names>A.</given-names></name></person-group><year>1998</year>. <article-title>Recovery from sevoflurane anesthesia in
horses: comparison to isoflurane and effect of postmedication with
xylazine</article-title>. <source><italic>Vet.
Surg.</italic></source><volume>27</volume>: <fpage>480</fpage>&#x02013;<lpage>485</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1532-950X.1998.tb00160.x</pub-id><pub-id pub-id-type="pmid">9749520</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Muir</surname><given-names>W.</given-names></name><name><surname>Lerche</surname><given-names>P.</given-names></name><name><surname>Wiese</surname><given-names>A.</given-names></name><name><surname>Nelson</surname><given-names>L.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name><name><surname>Whittem</surname><given-names>T.</given-names></name></person-group><year>2008</year>. <article-title>Cardiorespiratory and anesthetic effects
of clinical and supraclinical doses of alfaxalone in dogs</article-title>.
<source><italic>Vet. Anaesth. Analg.</italic></source><volume>35</volume>:
<fpage>451</fpage>&#x02013;<lpage>462</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2008.00406.x</pub-id><pub-id pub-id-type="pmid">18793290</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Muir</surname><given-names>W.</given-names></name><name><surname>Lerche</surname><given-names>P.</given-names></name><name><surname>Wiese</surname><given-names>A.</given-names></name><name><surname>Nelson</surname><given-names>L.</given-names></name><name><surname>Pasloske</surname><given-names>K.</given-names></name><name><surname>Whittem</surname><given-names>T.</given-names></name></person-group><year>2009</year>. <article-title>The cardiorespiratory and anesthetic
effects of clinical and supraclinical doses of alfaxalone in cats</article-title>.
<source><italic>Vet. Anaesth. Analg.</italic></source><volume>36</volume>:
<fpage>42</fpage>&#x02013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-2995.2008.00428.x</pub-id><pub-id pub-id-type="pmid">19121158</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Muir</surname><given-names>W. W.</given-names><suffix>3rd</suffix></name><name><surname>Gadawski</surname><given-names>J. E.</given-names></name></person-group><year>1998</year>. <article-title>Respiratory depression and apnea induced
by propofol in dogs</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>59</volume>: <fpage>157</fpage>&#x02013;<lpage>161</lpage>.
<pub-id pub-id-type="pmid">9492929</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Muir</surname><given-names>W. W.</given-names></name><name><surname>Skarda</surname><given-names>R. T.</given-names></name><name><surname>Sheehan</surname><given-names>W.</given-names></name></person-group><year>1978</year>. <article-title>Evaluation of xylazine, guaifenesin, and
ketamine hydrochloride for restraint in horses</article-title>. <source><italic>Am. J.
Vet. Res.</italic></source><volume>39</volume>:
<fpage>1274</fpage>&#x02013;<lpage>1278</lpage>. <pub-id pub-id-type="pmid">697134</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Nolan</surname><given-names>A. M.</given-names></name><name><surname>Chambers</surname><given-names>J. P.</given-names></name></person-group><year>1989</year>
<article-title>The use of propofol as an induction agent
after detomidine premedication in ponies</article-title>. <source><italic>J. Assoc. Vet.
Anaeth.</italic></source><volume>16</volume>:
<fpage>30</fpage>&#x02013;<lpage>32</lpage>.</mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Nolan</surname><given-names>A. M.</given-names></name><name><surname>Hall</surname><given-names>L. W.</given-names></name></person-group><year>1985</year>. <article-title>Total intravenous anaesthesia in the
horse with propofol</article-title>. <source><italic>Equine Vet.
J.</italic></source><volume>17</volume>: <fpage>394</fpage>&#x02013;<lpage>398</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.2042-3306.1985.tb02533.x</pub-id><pub-id pub-id-type="pmid">3876928</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Nolan</surname><given-names>A.</given-names></name><name><surname>Reid</surname><given-names>J.</given-names></name><name><surname>Welsh</surname><given-names>E.</given-names></name><name><surname>Flaherty</surname><given-names>D.</given-names></name><name><surname>McCormack</surname><given-names>R.</given-names></name><name><surname>Monteiro</surname><given-names>A. M.</given-names></name></person-group><year>1996</year>. <article-title>Simultaneous infusions of propofol and
ketamine in ponies premedicated with detomidine: a pharmacokinetic
study</article-title>. <source><italic>Res. Vet.
Sci.</italic></source><volume>60</volume>: <fpage>262</fpage>&#x02013;<lpage>266</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S0034-5288(96)90051-X</pub-id><pub-id pub-id-type="pmid">8735519</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Oku</surname><given-names>K.</given-names></name><name><surname>Kakizaki</surname><given-names>M.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name></person-group><year>2011</year>. <article-title>Clinical evaluation of total intravenous
anesthesia using a combination of propofol and medetomidine following anesthesia
induction with medetomidine, guaifenesin and propofol for castration in Thoroughbred
horses</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>73</volume>: <fpage>1639</fpage>&#x02013;<lpage>1643</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.11-0153</pub-id><pub-id pub-id-type="pmid">21791888</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Oku</surname><given-names>K.</given-names></name><name><surname>Yamanaka</surname><given-names>T.</given-names></name><name><surname>Ashihara</surname><given-names>N.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name><name><surname>Mizuno</surname><given-names>Y.</given-names></name><name><surname>Fujinaga</surname><given-names>T.</given-names></name></person-group><year>2003</year>. <article-title>Clinical observations during induction
and recovery of xylazine-midazolam- propofol anesthesia in horses</article-title>.
<source><italic>J. Vet. Med. Sci.</italic></source><volume>65</volume>:
<fpage>805</fpage>&#x02013;<lpage>808</lpage>. doi: <pub-id pub-id-type="doi">10.1292/jvms.65.805</pub-id><pub-id pub-id-type="pmid">12939509</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group><name><surname>Ohta</surname><given-names>M.</given-names></name><name><surname>Oku</surname><given-names>K.</given-names></name><name><surname>Mukai</surname><given-names>K.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Mizuno</surname><given-names>Y.</given-names></name></person-group><year>2004</year>. <article-title>Propofol-ketamine anesthesia for internal
fixation of fractures in racehorses</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>66</volume>: <fpage>1433</fpage>&#x02013;<lpage>1436</lpage>.
doi: <pub-id pub-id-type="doi">10.1292/jvms.66.1433</pub-id><pub-id pub-id-type="pmid">15585962</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group><name><surname>Santos</surname><given-names>M.</given-names></name><name><surname>Fuente</surname><given-names>M.</given-names></name><name><surname>Garcia-Iturralde</surname><given-names>R.</given-names></name><name><surname>Herran</surname><given-names>R.</given-names></name><name><surname>Lopez-Sanroman</surname><given-names>J.</given-names></name><name><surname>Tendillo</surname><given-names>F. J.</given-names></name></person-group><year>2003</year>. <article-title>Effects of alpha-2 adrenoceptor agonists
during recovery from isoflurane anaesthesia in horses</article-title>.
<source><italic>Equine Vet. J.</italic></source><volume>35</volume>:
<fpage>170</fpage>&#x02013;<lpage>175</lpage>. doi: <pub-id pub-id-type="doi">10.2746/042516403776114117</pub-id><pub-id pub-id-type="pmid">12638794</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group><name><surname>Sebel</surname><given-names>P. S.</given-names></name><name><surname>Lowdon</surname><given-names>J. D.</given-names></name></person-group><year>1989</year>. <article-title>Propofol: a new intravenous
anesthetic</article-title>.
<source><italic>Anesthesiology</italic></source><volume>71</volume>:
<fpage>260</fpage>&#x02013;<lpage>277</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00000542-198908000-00015</pub-id><pub-id pub-id-type="pmid">2667401</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group><name><surname>Valverde</surname><given-names>A.</given-names></name></person-group><year>2010</year>. <article-title>Alpha-2 agonists as pain therapy in
horses</article-title>. <source><italic>Vet. Clin. North Am. Equine
Pract.</italic></source><volume>26</volume>: <fpage>515</fpage>&#x02013;<lpage>532</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.cveq.2010.07.003</pub-id><pub-id pub-id-type="pmid">21056297</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group><name><surname>Wakuno</surname><given-names>A.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Kushiro</surname><given-names>A.</given-names></name><name><surname>Mae</surname><given-names>N.</given-names></name><name><surname>Kodaira</surname><given-names>K.</given-names></name><name><surname>Maeda</surname><given-names>T.</given-names></name><name><surname>Yamazaki</surname><given-names>Y.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name></person-group><year>2017</year>. <article-title>Comparison of alfaxalone, ketamine and
thiopental for anaesthetic induction and recovery in Thoroughbred horses premedicated
with medetomidine and midazolam</article-title>. <source><italic>Equine Vet.
J.</italic></source><volume>49</volume>: <fpage>94</fpage>&#x02013;<lpage>98</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/evj.12548</pub-id><pub-id pub-id-type="pmid">26850885</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Tsubakishita</surname><given-names>S.</given-names></name><name><surname>Futaok</surname><given-names>S.</given-names></name><name><surname>Ueda</surname><given-names>I.</given-names></name><name><surname>Hamaguchi</surname><given-names>H.</given-names></name><name><surname>Seno</surname><given-names>T.</given-names></name><name><surname>Katoh</surname><given-names>S.</given-names></name><name><surname>Izumisawa</surname><given-names>Y.</given-names></name><name><surname>Kotani</surname><given-names>T.</given-names></name><name><surname>Muir</surname><given-names>W. W.</given-names></name></person-group><year>2000</year>. <article-title>Cardiovascular effects of medetomidine,
detomidine and xylazine in horses</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>62</volume>: <fpage>1025</fpage>&#x02013;<lpage>1032</lpage>.
doi: <pub-id pub-id-type="doi">10.1292/jvms.62.1025</pub-id><pub-id pub-id-type="pmid">11073071</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group><name><surname>Young</surname><given-names>L. E.</given-names></name><name><surname>Bartram</surname><given-names>D. H.</given-names></name><name><surname>Diamond</surname><given-names>M. J.</given-names></name><name><surname>Gregg</surname><given-names>A. S.</given-names></name><name><surname>Jones</surname><given-names>R. S.</given-names></name></person-group><year>1993</year>. <article-title>Clinical evaluation of an infusion of
xylazine, guaifenesin and ketamine for maintenance of anaesthesia in
horses</article-title>. <source><italic>Equine Vet.
J.</italic></source><volume>25</volume>: <fpage>115</fpage>&#x02013;<lpage>119</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.2042-3306.1993.tb02919.x</pub-id><pub-id pub-id-type="pmid">8467769</pub-id></mixed-citation></ref></ref-list></back></article>